DiaMedica Therapeutics Inc.
DMAC
$8.51
$0.536.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 18.81% | -12.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.81% | -1.68% | |||
| Operating Income | -12.81% | 1.68% | |||
| Income Before Tax | -11.97% | 0.10% | |||
| Income Tax Expenses | 0.00% | 0.00% | |||
| Earnings from Continuing Operations | -11.96% | 0.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.96% | 0.10% | |||
| EBIT | -12.81% | 1.68% | |||
| EBITDA | -12.63% | 1.59% | |||
| EPS Basic | 3.07% | 0.39% | |||
| Normalized Basic EPS | 3.04% | 0.36% | |||
| EPS Diluted | 3.07% | 0.39% | |||
| Normalized Diluted EPS | 3.04% | 0.36% | |||
| Average Basic Shares Outstanding | 15.53% | 0.27% | |||
| Average Diluted Shares Outstanding | 15.53% | 0.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||